{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:40:33Z","timestamp":1791520833991,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T00:00:00Z","timestamp":1297987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11154-011-9163-7","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T10:53:51Z","timestamp":1297940031000},"page":"43-48","source":"Crossref","is-referenced-by-count":70,"title":["Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism"],"prefix":"10.1007","volume":"12","author":[{"given":"Evelyn","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"issue":"3","key":"9163_CR1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89(3):1045\u201350.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9163_CR2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1365-2265.2003.01817.x","volume":"59","author":"PL Padfield","year":"2003","unstructured":"Padfield PL. Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice. Clin Endocrinol (Oxf). 2003;59(4):422\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"9163_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jc.2004-1149","volume":"90","author":"SC Tiu","year":"2005","unstructured":"Tiu SC et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab. 2005;90(1):72\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9163_CR4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","volume":"31","author":"VM Montori","year":"2002","unstructured":"Montori VM, Young Jr WF. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am. 2002;31(3):619\u201332. xi.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"9163_CR5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2265.2003.01841.x","volume":"59","author":"PO Lim","year":"2003","unstructured":"Lim PO, MacDonald TM. Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension. Clin Endocrinol (Oxf). 2003;59(4):427\u201330.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"9163_CR6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tem.2005.02.007","volume":"16","author":"P Mulatero","year":"2005","unstructured":"Mulatero P et al. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab. 2005;16(3):114\u20139.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"9163_CR7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","volume":"51","author":"GL Schwartz","year":"2005","unstructured":"Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem. 2005;51(2):386\u201394.","journal-title":"Clin Chem"},{"issue":"6","key":"9163_CR8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0030-1248326","volume":"42","author":"A Tomaschitz","year":"2010","unstructured":"Tomaschitz A, Pilz S. Aldosterone to renin ratio\u2014a reliable screening tool for primary aldosteronism? Horm Metab Res. 2010;42(6):382\u201391.","journal-title":"Horm Metab Res"},{"issue":"5","key":"9163_CR9","first-page":"220","volume":"66","author":"PM Jansen","year":"2008","unstructured":"Jansen PM, Boomsma F, van den Meiracker AH. Aldosterone-to-renin ratio as a screening test for primary aldosteronism\u2014the Dutch ARRAT Study. Neth J Med. 2008;66(5):220\u20138.","journal-title":"Neth J Med"},{"issue":"9","key":"9163_CR10","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9163_CR11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0030-1247545","volume":"42","author":"A Hannemann","year":"2010","unstructured":"Hannemann A et al. Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1). Horm Metab Res. 2010;42(6):392\u20139.","journal-title":"Horm Metab Res"},{"issue":"4","key":"9163_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","volume":"57","author":"C Seifarth","year":"2002","unstructured":"Seifarth C et al. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol (Oxf). 2002;57(4):457\u201365.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"9163_CR13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P et al. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002;40(6):897\u2013902.","journal-title":"Hypertension"},{"issue":"3","key":"9163_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/eje.0.1500329","volume":"150","author":"L Seiler","year":"2004","unstructured":"Seiler L et al. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol. 2004;150(3):329\u201337.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"9163_CR15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","volume":"37","author":"BJ Gallay","year":"2001","unstructured":"Gallay BJ et al. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis. 2001;37(4):699\u2013705.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"9163_CR16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","volume":"3","author":"AS Bomback","year":"2007","unstructured":"Bomback AS, Klemmer PJ. The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol. 2007;3(9):486\u201392.","journal-title":"Nat Clin Pract Nephrol"},{"issue":"8","key":"9163_CR17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00059-003-2507-7","volume":"28","author":"L Seiler","year":"2003","unstructured":"Seiler L, Reincke M. The aldosterone to Renin ratio in secondary hypertension. Herz. 2003;28(8):686\u201391.","journal-title":"Herz"},{"issue":"9","key":"9163_CR18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4065\/76.9.877","volume":"76","author":"VM Montori","year":"2001","unstructured":"Montori VM et al. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc. 2001;76(9):877\u201382.","journal-title":"Mayo Clin Proc"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-011-9163-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-011-9163-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-011-9163-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:31:24Z","timestamp":1559363484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-011-9163-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,18]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9163"],"URL":"https:\/\/doi.org\/10.1007\/s11154-011-9163-7","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,18]]}}}